Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QScreen AIPMEDF -26.10% EV-to-EBIT is -6.10 as of Aug. 02, 2026. The stock has 1 warning sign investors should review. Among 470 Medical Devices & Instruments companies, QScreen AI ranks worse than 212765.74% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
QScreen AI's Enterprise Value for the quarter that ended in Jan. 2026 was $9.16 Mil.
QScreen AI's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.86 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QScreen AI EV-to-EBIT Related Terms
QScreen AI EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for QScreen AI's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, QScreen AI's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QScreen AI EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QScreen AI's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where QScreen AI's EV-to-EBIT falls into.
QScreen AI's current Enterprise Value is $5.25 Mil.
QScreen AI's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.86 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QScreen AI (PMEDF) has a EV-to-EBIT of -6.10 as of Aug. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on QScreen AI and its competitors. According to the industry distribution chart, QScreen AI ranks #999999 out of 470 companies in the Medical Devices & Instruments industry.
Is QScreen AI's EV-to-EBIT too high?
QScreen AI's current EV-to-EBIT is -6.10. Based on the distribution chart, QScreen AI ranks #999999 out of 470 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does QScreen AI's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, QScreen AI ranks #999999 out of 470 companies for EV-to-EBIT. This places QScreen AI in the lower half of its industry. The industry median EV-to-EBIT is 18.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.85, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on QScreen AI and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QScreen AI's current EV-to-EBIT is -6.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QScreen AI stock overvalued right now?
QScreen AI (PMEDF) has a current EV-to-EBIT of -6.10. The current EV-to-EBIT is -6.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For QScreen AI (PMEDF), the current EV-to-EBIT is -6.10 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
QScreen AI Inc is focused on developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company's business is focused on artificial intelligence (AI) technologies targeting two specific areas: workplace health and safety and healthcare. It is building a proprietary artificial intelligence engine with quantum inspired computing and physiological sensing to clinical and occupational health assessments across correctional facilities, addiction medicine rehabilitation, and industrial workforce screening in multiple jurisdictions. It operates in single segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMEDF has been successfully added to your 
